Overview

Kidney Allograft Dysfunction Without Reversible Causes

Status:
Withdrawn
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn the best way to prolong kidney life in patients exposed to calcineurin inhibitors, who already have evidence of damage possibly caused by the calcineurin inhibitor on kidney biopsy.
Phase:
Phase 4
Details
Lead Sponsor:
University of Minnesota
University of Minnesota - Clinical and Translational Science Institute
Treatments:
Calcineurin Inhibitors
Cyclosporine
Cyclosporins
Sirolimus
Tacrolimus